Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2021 05:00 ET | Source: Genetron Holdings Limited

Genetron Health Announces Publication of Enhanced Variant Caller Performance Data in Briefings in Bioinformatics

BEIJING, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
November 08, 2021 05:00 ET | Source: Genetron Holdings Limited

Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Oncology Drug Research and Development

BEIJING, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
November 04, 2021 16:05 ET | Source: Genetron Holdings Limited

Genetron Health to Announce Third Quarter 2021 Financial Results and Host Investor Call on November 30, 2021

BEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
November 04, 2021 06:00 ET | Source: Genetron Holdings Limited

Genetron Health’s Multi-Gene Mutation Detection Kit Onco PanScan™ Obtains CE Mark

BEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
November 03, 2021 02:00 ET | Source: Genetron Holdings Limited

Genetron Health Wins Second Prize of China’s National Science and Technology Progress Award for Contributions to Lung Cancer Precision Medicine Project

BEIJING, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
October 28, 2021 00:38 ET | Source: Genetron Holdings Limited

Genetron Health’s Liver Cancer Screening Results and Technology Findings Included in the Chinese Journal of Hepatology

BEIJING, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
October 22, 2021 07:00 ET | Source: Genetron Holdings Limited

Genetron Health and Fosun Pharma Announce Exclusive Partnership to Commercialize Seq-MRD® in China

SHANGHAI, China, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that...
September 27, 2021 06:00 ET | Source: Genetron Holdings Limited

Genetron Health and IMPACT Therapeutics Announce Partnership to Drive Development of Synthetic Lethal Product Pipeline

BEIJING, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
September 16, 2021 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Unveils 13 Cancer Research findings at ESMO Congress 2021

BEIJING, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
September 03, 2021 11:07 ET | Source: Genetron Holdings Limited

Genetron Added to FTSE Russell Global Equity Index Series

BEIJING, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that Genetron will be added to the below FTSE Global Equity...